In this context, aim of our study was to investigate expression of IFN-γ, IL-17, IL-23 and IL-22 in BCC and their modulation during IMQ 5% cream or MAL-PDT treatment. The gene discussed is IL17A; the disease is skin basal cell carcinoma.